IRIDEX Corp
IRIX
查看详细走势图
1.000USD
+0.030+3.09%
收盘 12/19, 16:00（美东）报价延迟15分钟
17.05M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+3.09%
5天
+8.60%
1月
+6.38%
6月
+7.18%
今年开始到现在
-40.48%
1年
-39.02%
查看详细走势图
TradingKey IRIDEX Corp股票评分
单位: USD 更新时间: 2025-12-19操作建议
IRIDEX Corp当前公司基本面数据相对健康，增长潜力较大。当前估值合理，在医疗设备与耗材行业排名150/208位。机构持股占比非常高，中期看，股价处于平稳状态。近一个月，市场表现较强，技术面和基本面综合得分较高，较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
IRIDEX Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
--
目标均价
--
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
IRIDEX Corp亮点
亮点风险
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
业绩增长期
公司处于发展阶段，最新年度总收入48.67M美元
利润高增长
公司净利润处于行业前列，最新年度总收入48.67M美元
估值合理
公司最新PE估值-3.32，处于3年历史合理位
机构减仓
最新机构持股2.61M股，环比减少16.95%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓，最新持仓市值389.06K
活跃度降低
近期活跃度降低，过去20天平均换手率0.39
IRIDEX Corp新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
IRIDEX Corp简介
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
公司代码IRIX
公司IRIDEX Corp
CEOMercer (Patrick)
网址https://www.iridex.com/
常见问题
IRIDEX Corp(IRIX)的当前股价是多少？
IRIDEX Corp(IRIX)的当前股价是 1.000。
IRIDEX Corp的股票代码是什么？
IRIDEX Corp的股票代码是IRIX。
IRIDEX Corp股票的52周最高点是多少？
IRIDEX Corp股票的52周最高点是1.890。
IRIDEX Corp股票的52周最低点是多少？
IRIDEX Corp股票的52周最低点是0.782。
IRIDEX Corp的市值是多少？
IRIDEX Corp的市值是17.05M。
IRIDEX Corp的净利润是多少？
IRIDEX Corp的净利润为-8.91M。
现在IRIDEX Corp(IRIX)的股票是买入、持有还是卖出？
根据分析师评级，IRIDEX Corp(IRIX)的总体评级为--，目标价格为--。
IRIDEX Corp(IRIX)股票的每股收益（EPS TTM）是多少
IRIDEX Corp(IRIX)股票的每股收益（EPS TTM）是-0.301。
相关品种
-0.24%
+0.25%
+0.87%
+1.88%
+0.22%
-0.55%
+0.53%
+0.12%
+1.35%
-0.10%
-1.23%
-0.77%
+0.10%
+0.46%
+0.46%
+0.97%
+0.59%
+0.23%
+0.45%
+1.74%
